AU1383495A - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
AU1383495A
AU1383495A AU13834/95A AU1383495A AU1383495A AU 1383495 A AU1383495 A AU 1383495A AU 13834/95 A AU13834/95 A AU 13834/95A AU 1383495 A AU1383495 A AU 1383495A AU 1383495 A AU1383495 A AU 1383495A
Authority
AU
Australia
Prior art keywords
pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU13834/95A
Other versions
AU697290B2 (en
Inventor
Ronald James Boon
David Ronald John Griffin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
Original Assignee
Novartis International Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis International Pharmaceutical Ltd filed Critical Novartis International Pharmaceutical Ltd
Publication of AU1383495A publication Critical patent/AU1383495A/en
Application granted granted Critical
Publication of AU697290B2 publication Critical patent/AU697290B2/en
Assigned to NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD reassignment NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD Alteration of Name(s) in Register under S187 Assignors: SMITHKLINE BEECHAM PLC
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU13834/95A 1993-12-22 1994-12-14 Pharmaceuticals Expired AU697290B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939326177A GB9326177D0 (en) 1993-12-22 1993-12-22 Pharmaceuticals
GB9326177 1993-12-22
PCT/EP1994/004163 WO1995017190A1 (en) 1993-12-22 1994-12-14 Pharmaceuticals

Publications (2)

Publication Number Publication Date
AU1383495A true AU1383495A (en) 1995-07-10
AU697290B2 AU697290B2 (en) 1998-10-01

Family

ID=10747023

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13834/95A Expired AU697290B2 (en) 1993-12-22 1994-12-14 Pharmaceuticals

Country Status (8)

Country Link
EP (1) EP0735878A1 (en)
JP (1) JPH09506883A (en)
CN (1) CN1084622C (en)
AU (1) AU697290B2 (en)
CA (1) CA2179282A1 (en)
GB (1) GB9326177D0 (en)
WO (1) WO1995017190A1 (en)
ZA (1) ZA9410113B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19980028023A (en) * 1996-10-19 1998-07-15 김준웅 Ο-acyl-Ο-amino acid 9- (4-hydroxy-3-hydroxymethylbut-1-ylguanine ester derivative

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3485225D1 (en) * 1983-08-18 1991-12-05 Beecham Group Plc ANTIVIRAL GUANINE DERIVATIVES.
EP0182024B1 (en) * 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use
DE3671227D1 (en) * 1985-07-27 1990-06-21 Beecham Group Plc 9-SUBSTITUTED GUANINE MONOHYDRATES.
GB8628826D0 (en) * 1986-12-02 1987-01-07 Beecham Group Plc Pharmaceutical products
GB8904855D0 (en) * 1989-03-03 1989-04-12 Beecham Group Plc Pharmaceutical treatment
GB8917959D0 (en) * 1989-08-05 1989-09-20 Beecham Group Plc Pharmaceutical formulation
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
GB9015051D0 (en) * 1990-07-07 1990-08-29 Beecham Group Plc Pharmaceutical treatment
GB9114939D0 (en) * 1991-07-11 1991-08-28 Smithkline Beecham Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
CN1142769A (en) 1997-02-12
AU697290B2 (en) 1998-10-01
GB9326177D0 (en) 1994-02-23
WO1995017190A1 (en) 1995-06-29
ZA9410113B (en) 1995-08-25
JPH09506883A (en) 1997-07-08
CN1084622C (en) 2002-05-15
CA2179282A1 (en) 1995-06-29
EP0735878A1 (en) 1996-10-09

Similar Documents

Publication Publication Date Title
AU7583794A (en) 1-amino-ethylindole-derivatives
AU6001594A (en) Imidazoazines
AU1209592A (en) Pharmaceuticals
AU6710294A (en) Tetrahydro-beta-carbolines
AU6705294A (en) Tetrahydro-pyrido-indole
AU5798394A (en) Thiadiazinones
AU6259294A (en) Life-savingfloat
GB9305593D0 (en) Pharmaceuticals
GB9301660D0 (en) Pharmaceuticals
AU6389494A (en) Tv-projector
AU1274295A (en) Heteroarylpyrroles
AU8104694A (en) Bagbottle
AU6971594A (en) Cyclobutylazoles
AP9400684A0 (en) Pharmaceuticals
AU6427194A (en) Aza-androstane-17beta -carboxamides
GB9303340D0 (en) Pharmaceuticals
AU3696093A (en) Aquamate
AU5780894A (en) Crankhead
AU7285994A (en) Suncap
AU1383495A (en) Pharmaceuticals
AU5830994A (en) Zusammenklappbares baukastensystem
AU6726594A (en) Tee-box
AU674745B2 (en) Eco-brick
AU8142394A (en) Alkyl-n-pyrroles
AU7000494A (en) Aralkylaminoquinazolines

Legal Events

Date Code Title Description
PC Assignment registered

Owner name: NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD

Free format text: FORMER OWNER WAS: SMITHKLINE BEECHAM PLC